The tumor cell growth simulated by high concentrations of insulin through the activation of IGF‐1, and the possible protective effect of the use of metformin (found in a meta‐analysis including 12 cohort studies, seven case‐controls studies, and one RCT)32 on CRC development further supports the insulin‐CRC association. This evidence concerns the gene IGF1 and colorectal carcinoma.